Erythropoietin: A Breakthrough in Chronic Disease Care
The landscape of chronic disease management has witnessed a revolutionary shift with the advent of erythropoietin (EPO) therapy. Naturally produced by the kidneys, this glycoprotein hormone has transcended its physiological role to become a cornerstone in treating various chronic conditions, particularly anemia associated with chronic kidney disease (CKD), cancer, and other debilitating diseases. This transformation…